Evidence map›Paper›PMID 38686958›Full record

ArticleNanomedicine (London, England)2024

Studies on cationic ocular emulsions containing bipartitioned oil droplets to codeliver cyclosporin A and etodolac.

Syed Nazrin Ruhina Rahman, Abhinab Goswami, Aishwarya Jala, Animith Venuganti, Apurba Deka, Roshan M Borkar, Vivek Singh, Dipankar Das, Tamilvanan Shunmugaperumal

Abstract read
In one paragraph

Article in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Syed Nazrin Ruhina RahmanDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam, 781101, India.ORCID 0000-0003-0046-5628
Abhinab GoswamiDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam, 781101, India.ORCID 0000-0001-6356-6827
Aishwarya JalaDepartment of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam, 781101, India.ORCID 0000-0001-9663-2907
Animith VenugantiCenter for Ocular Regeneration, LV Prasad Eye Institute, Hyderabad, 500034, India.
Apurba DekaDepartment of Ocular Pathology, Sri Sankaradeva Nethralaya, Guwahati, Assam, 781028, India.
Roshan M BorkarDepartment of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam, 781101, India.ORCID 0000-0003-1963-7688
Vivek SinghCenter for Ocular Regeneration, LV Prasad Eye Institute, Hyderabad, 500034, India.ORCID 0000-0003-3958-5635
Dipankar DasDepartment of Ocular Pathology, Sri Sankaradeva Nethralaya, Guwahati, Assam, 781028, India.ORCID 0000-0001-5699-3767
Tamilvanan ShunmugaperumalDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, Assam, 781101, India.ORCID 0000-0001-7338-3207

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CyclosporineEmulsionsEtodolacAnimalsCastor OilCationsCorneaDrug LiberationDry Eye SyndromesHumansOlive OilOphthalmic SolutionsParticle SizeRabbitsSilicone OilsTissue DistributionCastor OilCationsCyclosporineEmulsionsEtodolacOlive OilOphthalmic SolutionsSilicone Oilsanti-inflammatorycyclosporin Adry eye diseaseetodolacnanosized emulsions

Identifiers

PMID38686958
PMCPMC11221375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.